Icon

Gimoti - (15 mg/spray ; Metered Nasal Spray)

Metoclopramide Hydrochloride Evoke pharma
15 mg/spray ; Metered Nasal Spray
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
GIMOTI is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Yes
***** ** **** *** ***, *.*. ****. **** ********* *** *********** ** * ****-*** ********* ** ***** ******* **** ***** (*****://**************.***-***.***/****-********/****-*******-*******/*****-*********-****-****-*******-*********-**-****-*******) ******* **** ******** **** *** ******* ** *******. *** ** ****** ****, **** *** ****** ** ******
Gimoti Patent 1 Patent 2
**** ********* ** **** *** ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** / ********* *** **, **** ********* ** *** *** ********* ******** ** ** ****
  1. *** **, **** : * **** ** *** ***** *** ***** ** * *** *******.
  2. *** **, **** : **** ******** ***** ***** *** **** ** ******.
  3. *** *, **** : ***** **** **** ** ******* '***(*** **, ****) *** '*** (*** **, ****).
  4. *** **, **** : ***** ********* ********** ******* ****. ********* ** *****'* ***** *******, **** **** *** ***** ***** **** ******* *** ****-** ** * ****-*** ***********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.